-
1
Distinct expression profile reveals glia involvement in the trigeminal system attributing to post-traumatic headache
Published 2024-11-01“…The Journal of Headache and Pain…”
Get full text
Article -
2
Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population
Published 2024-02-01“…The Journal of Headache and Pain…”
Get full text
Article -
3
Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature
Published 2019-12-01“…The Journal of Headache and Pain…”
Get full text
Article -
4
Pediatric migraine is characterized by traits of ecological and metabolic dysbiosis and inflammation
Published 2024-10-01“…The Journal of Headache and Pain…”
Get full text
Article -
5
Decoding pain through facial expressions: a study of patients with migraine
Published 2024-03-01“…The Journal of Headache and Pain…”
Get full text
Article -
6
Shared and independent roles of CGRP and PACAP in migraine pathophysiology
Published 2023-04-01“…The Journal of Headache and Pain…”
Get full text
Article -
7
CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society
Published 2024-03-01“…The Journal of Headache and Pain…”
Get full text
Article -
8
Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre
Published 2019-12-01“…The Journal of Headache and Pain…”
Get full text
Article -
9
Real-world effectiveness of Anti-CGRP monoclonal antibodies compared to OnabotulinumtoxinA (RAMO) in chronic migraine: a retrospective, observational, multicenter, cohort study
Published 2024-02-01“…The Journal of Headache and Pain…”
Get full text
Article -
10
The effect and safety of monoclonal antibodies to calcitonin gene-related peptide and its receptor on migraine: a systematic review and meta-analysis
Published 2017-04-01“…The Journal of Headache and Pain…”
Get full text
Article -
11
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort
Published 2023-04-01“…The Journal of Headache and Pain…”
Get full text
Article -
12
Spreading depression as a preclinical model of migraine
Published 2019-05-01“…The Journal of Headache and Pain…”
Get full text
Article -
13
A PRISMA-compliant systematic review of the endpoints employed to evaluate symptomatic treatments for primary headaches
Published 2018-09-01“…The Journal of Headache and Pain…”
Get full text
Article -
14
Burden of migraine among Japanese patients: a cross-sectional National Health and Wellness Survey
Published 2020-09-01“…The Journal of Headache and Pain…”
Get full text
Article -
15
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
Published 2024-03-01“…The Journal of Headache and Pain…”
Get full text
Article -
16
Trends in migraine incidence among women of childbearing age from 1990 to 2019 and the prediction for 2030: an analysis of national data in China
Published 2023-11-01“…The Journal of Headache and Pain…”
Get full text
Article -
17
Interrelations between migraine-like headache and persistent post-traumatic headache attributed to mild traumatic brain injury: a prospective diary study
Published 2020-11-01“…The Journal of Headache and Pain…”
Get full text
Article -
18
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine
Published 2022-08-01“…The Journal of Headache and Pain…”
Get full text
Article -
19
Prevalence of familial cluster headache: a systematic review and meta-analysis
Published 2020-04-01“…The Journal of Headache and Pain…”
Get full text
Article -
20
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
Published 2022-11-01“…The Journal of Headache and Pain…”
Get full text
Article